Clinical Trials
30 trialsThe Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients
Sun Yat-sen University
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
PLANET
Fundación GECP
InvestiCAT
University Medical Center Groningen
GENTIS
CHA University
Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
City of Hope Medical Center
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
Peking University Cancer Hospital & Institute
Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC
Sun Yat-sen University
HRCC1
Azienda Policlinico Umberto I
CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]
Aetion, Inc.
CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS4]
Aetion, Inc.
CIN
Swami Rama Himalayan University
Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
University Medical Center Groningen
B7-Family Score in Urothelial Carcinoma
Shanghai Zhongshan Hospital
Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer
Peking University Third Hospital
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients
Ain Shams University
QUASAR
University of California, San Diego
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers
Holy Name Medical Center, Inc.
Definitive Concurrent Hypofractionated Rth With Weekly Cisplatin in Locally Advanced SCCHN
Assiut University
Immunotherapy in Lung Cancer: Treatment After IO Cessation.
European Lung Cancer Working Party
Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients
Sun Yat-sen University
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
Sungkyunkwan University
Breast Cancer Treatment Based on Organ-like Culture
Xijing Hospital
xenoZ
University of Pisa
Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
Wake Forest University Health Sciences
Thrombin Generation and Platelet Activation in CRS/HIPEC
Ziekenhuis Oost-Limburg
The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
First People's Hospital of Foshan
Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel
Roswell Park Cancer Institute
A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Royal Marsden NHS Foundation Trust